Telehealth Prescribing Rules for Suboxone in 2026

If you're considering online treatment for opioid use disorder, you've probably wondered: Is it actually legal to get a Suboxone prescription through a video call? The answer is yes—but the regulations governing telehealth prescribing of buprenorphine (the active medication in Suboxone) have evolved significantly in recent years.
Understanding these rules matters. Knowing what's legal protects you as a patient and helps you find legitimate, safe treatment providers. The landscape changed dramatically during the COVID-19 pandemic, and while some flexibility has become permanent, the regulatory framework remains complex.
This guide explains the current federal and state regulations for telehealth Suboxone prescribing in 2026, with specific details for Virginia, Ohio, and Pennsylvania.
The Federal Framework: DEA Telehealth Flexibilities
The Drug Enforcement Administration (DEA) traditionally required an in-person medical evaluation before prescribing Schedule II-V controlled substances like buprenorphine. This was codified in the Ryan Haight Online Pharmacy Consumer Protection Act of 2008, which aimed to prevent illegal online pharmacies from distributing controlled substances without legitimate doctor-patient relationships.
During the COVID-19 public health emergency, the DEA issued temporary regulations allowing providers to prescribe buprenorphine via telehealth without a prior in-person visit. This expanded access dramatically—millions of people started online Suboxone treatment who might never have sought in-person care due to stigma, transportation barriers, or lack of local providers.
In 2023, the DEA proposed making many of these flexibilities permanent while adding some safeguards. As of 2026, the current federal rules allow:
- Initial buprenorphine prescriptions via audio-video telehealth without a prior in-person exam, provided the prescriber conducts a real-time interactive evaluation
- Ongoing prescriptions via telehealth for established patients
- Audio-only visits in limited circumstances when video isn't accessible, though providers must document why video wasn't feasible
The prescriber must be registered with the DEA, hold a valid state medical license, and comply with all state laws where the patient is located. They must also maintain proper medical records documenting the telehealth encounter just as they would for an in-person visit.
What the Ryan Haight Act Still Requires
While telehealth flexibilities have expanded, the Ryan Haight Act hasn't been repealed—it's been modified through regulatory interpretation. The law still requires a "legitimate medical purpose" and a bona fide doctor-patient relationship.
For buprenorphine prescribing, this means:
- Providers must conduct a comprehensive evaluation, including medical history, current symptoms, and substance use assessment
- The patient must be located in a state where the provider is licensed
- Prescriptions must be sent to legitimate pharmacies, not questionable online-only operations
- Providers cannot prescribe based solely on a questionnaire or without real-time interaction
Importantly, you cannot legally obtain Suboxone from websites that don't require a video evaluation with a licensed provider. If a service offers to ship buprenorphine based only on filling out a form, it's likely operating illegally and potentially dangerous.
State-Specific Regulations: Virginia, Ohio, and Pennsylvania
While federal DEA rules set the baseline, states can impose additional requirements. Here's what you need to know if you live in Virginia, Ohio, or Pennsylvania.
Virginia Telehealth Prescribing Rules
Virginia has been relatively progressive with telehealth regulations. The state allows:
- Initial buprenorphine prescriptions via telehealth without requiring an in-person visit first
- Audio-video or audio-only visits, though audio-video is strongly preferred
- Out-of-state providers to prescribe to Virginia residents if they hold a Virginia medical license or practice through an interstate compact
Virginia law requires providers to establish a bona fide provider-patient relationship, which can be done through telehealth for medication-assisted treatment. The Virginia Board of Medicine has issued guidance affirming that telehealth-only treatment for opioid use disorder meets the standard of care when conducted appropriately.
Patients in Virginia can access treatment through Grata Health's telehealth platform with confidence that it complies with all state regulations. We serve patients throughout the state, from Richmond to Virginia Beach to rural communities with limited local addiction treatment options.
Ohio Telehealth Prescribing Rules
Ohio enacted comprehensive telehealth legislation that protects both patients and providers. Current Ohio law:
- Permits initial buprenorphine prescribing via telehealth after an audio-video evaluation
- Does not require in-person visits for medication-assisted treatment initiation or continuation
- Requires providers to be licensed in Ohio or practicing under an interstate compact
- Mandates audio-video interaction (not audio-only) for controlled substance prescribing in most cases
Ohio also requires providers to check the state's Prescription Drug Monitoring Program (PDMP) before prescribing controlled substances. This is a safety measure that helps identify potential drug interactions or concerning patterns, not a barrier to legitimate treatment.
The Ohio State Medical Board has clarified that telehealth-delivered medication-assisted treatment is appropriate and effective. Ohio patients from Columbus to Cleveland can access the same quality of care through telehealth as they would in person.
Pennsylvania Telehealth Prescribing Rules
Pennsylvania has maintained some additional safeguards while still allowing telehealth buprenorphine prescribing. Key provisions include:
- Initial prescriptions for buprenorphine can be issued via telehealth after an audio-video evaluation
- Providers must establish a provider-patient relationship through real-time interactive communication
- Pennsylvania law permits both in-state and out-of-state providers who are licensed in Pennsylvania to prescribe via telehealth
- The state requires PDMP checks before prescribing controlled substances
Pennsylvania's Department of Health has affirmed that telehealth is an acceptable modality for treating opioid use disorder. Patients throughout Pennsylvania—from Philadelphia to Pittsburgh and everywhere between—have legal access to telehealth Suboxone treatment.
One important note: Pennsylvania requires providers to document why in-person care isn't being provided, though access, convenience, and patient preference are all considered valid reasons. This is more of a documentation requirement than a barrier.
How Grata Health Complies with Telehealth Regulations
Grata Health's telehealth platform is designed to meet all federal and state requirements for buprenorphine prescribing. Here's how we ensure compliance:
Provider licensing: All our providers are licensed in the states where they see patients. We don't use interstate compacts or attempt to practice across unlicensed state lines.
Real-time evaluation: Every first telehealth appointment includes a comprehensive audio-video evaluation covering medical history, substance use patterns, current health status, and treatment goals.
PDMP monitoring: Our providers check state prescription monitoring databases before prescribing and monitor them throughout your treatment.
Legitimate pharmacy partnerships: We work only with licensed, NABP-accredited pharmacies. Your prescription is sent electronically to your chosen local pharmacy or a verified mail-order pharmacy.
Documentation standards: We maintain complete medical records documenting each visit, following the same standards as in-person addiction medicine practices.
Ongoing care: After your initial visit, you'll have regular follow-up appointments via telehealth to monitor your progress, adjust dosing if needed, and provide additional support.
Get started with Grata Health and schedule your first appointment today.
Insurance Coverage for Telehealth Prescribing
Most insurance plans, including Medicaid, now cover telehealth visits for buprenorphine prescribing at the same rate as in-person visits. This parity was established during the COVID emergency and has largely been maintained.
Coverage varies by plan and state:
- Medicaid in Virginia, Ohio, and Pennsylvania all cover telehealth addiction treatment
- Major commercial insurers like Aetna, Blue Cross Blue Shield, and Cigna provide telehealth coverage
- Some plans may require prior authorization, but this applies to both telehealth and in-person prescribing
If you're uninsured, Grata Health also offers transparent self-pay pricing for telehealth visits and medications.
Common Questions About Telehealth Prescribing Legality
Can I get Suboxone prescribed on my first video visit?
Yes. Federal and state regulations in VA, OH, and PA allow initial buprenorphine prescribing after a comprehensive telehealth evaluation. You don't need an in-person visit first.
Is audio-only (phone call) sufficient, or do I need video?
Federal regulations prefer audio-video but allow audio-only in limited circumstances. However, most state regulations (including Ohio and Pennsylvania) require video for controlled substance prescribing. Virginia is more flexible but strongly prefers video. At Grata Health, we conduct all initial evaluations via video to ensure we meet the highest standards.
Will my telehealth prescription work at any pharmacy?
Yes. Your electronic prescription is sent to a licensed pharmacy just like an in-person prescription. The pharmacist has no way of knowing (and doesn't need to know) whether your prescription came from a telehealth or in-person visit.
Can my provider prescribe across state lines?
No. Your provider must be licensed in the state where you're physically located during the telehealth visit. If you travel frequently between states, let your provider know—you may need to pause treatment or arrange for in-person care while out of state.
Are there any limits on how long I can receive telehealth prescribing?
No. There are no federal or state limits on the duration of telehealth treatment for opioid use disorder. Many patients continue telehealth treatment for months or years. Some eventually transition to in-person care, while others remain in telehealth indefinitely—both are legitimate options.
What to Expect in Your Telehealth Prescribing Visit
Understanding what happens during your telehealth video visit can help you prepare and ensure you receive appropriate care.
Your provider will:
- Review your medical history and current medications
- Discuss your substance use history and current patterns
- Assess for opioid use disorder using clinical criteria
- Screen for any medical contraindications to buprenorphine
- Explain how Suboxone treatment works and what to expect
- Develop a treatment plan tailored to your needs
- Send your prescription electronically to your chosen pharmacy
The visit typically lasts 30-45 minutes for an initial evaluation. Your provider will schedule follow-up visits to monitor your progress, usually weekly or biweekly at first, then monthly as you stabilize.
The Future of Telehealth Prescribing Regulations
Telehealth prescribing of buprenorphine is here to stay. The regulatory framework established during COVID has proven effective at expanding access without compromising patient safety. Multiple studies have shown that telehealth-delivered medication-assisted treatment produces outcomes equivalent to or better than traditional in-person care.
That said, regulations continue to evolve. The DEA periodically reviews its telehealth policies, and states update their laws as they gain more experience with remote prescribing. Staying informed helps you understand your rights and access the care you need.
Advocacy organizations continue pushing for further flexibility—particularly around audio-only visits for patients in areas with poor internet connectivity. As broadband access improves and telehealth becomes more normalized, we may see additional regulatory changes that make treatment even more accessible.
Finding Legitimate Telehealth Providers
With expanded telehealth prescribing, unfortunately, some illegitimate services have entered the market. Here's how to identify a legitimate provider:
Red flags to avoid:
- Services that prescribe without a real-time evaluation
- Websites that ship medications directly without pharmacy involvement
- Providers who don't verify your identity or location
- Services that guarantee prescriptions regardless of your clinical needs
- Unusually cheap prices that seem too good to be true
Green flags of legitimate care:
- Licensed providers who conduct comprehensive evaluations
- Real-time audio-video appointments (not just questionnaires)
- Prescriptions sent to licensed pharmacies
- Transparent pricing and insurance billing
- Follow-up care and ongoing monitoring
- Clear communication about state licensing and regulations
Grata Health meets all the criteria for legitimate telehealth prescribing. Our providers are licensed addiction medicine specialists who follow evidence-based protocols while treating every patient with compassion and respect.
Access Treatment That's Legal, Safe, and Effective
Telehealth prescribing of Suboxone is fully legal under current federal and state regulations in Virginia, Ohio, and Pennsylvania. You don't need to worry about traveling to a clinic, taking time off work, or facing potential stigma in a waiting room. You can receive the same quality of medical care from the privacy of your home.
Treatment for opioid use disorder works best when it's accessible, convenient, and delivered with compassion. Telehealth meets all these criteria while operating within a clear regulatory framework designed to protect patients.
If you're ready to start treatment or have questions about whether telehealth is right for you, schedule your first appointment with Grata Health. Our team is available to see patients throughout Virginia, Ohio, and Pennsylvania—often with same-day or next-day appointments.
You deserve care that fits your life and respects your dignity. Telehealth prescribing makes that possible within a safe, legal framework that puts your health first.
About the author
Editorial Team
The Grata Editorial Team produces evidence-based content on opioid use disorder, medication-assisted treatment, and recovery. Our writers work closely with licensed clinicians to ensure every article reflects the latest medical guidance and supports people seeking help for substance use disorders.
View full profileMedically reviewed by
Clinical Review Team
The Grata Care Team is a group of board-certified physicians and addiction medicine specialists who review all clinical content for accuracy. Our clinicians bring decades of combined experience in opioid use disorder treatment, buprenorphine prescribing, and telehealth-based addiction care.
View full profileReady to start your recovery?
Same-day telehealth appointments with licensed providers. Private, affordable, and covered by most insurance.
Get Care

